Skip to main content

News

Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.

News

Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.

Previous Common Colds Could Boost Risks of More Severe COVID-19

September 29, 2022 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

Having a common cold caused by seasonal coronaviruses may cause immune distraction, making some people’s immune systems respond less effectively to SARS-CoV-2 infection and increase their risk of more severe COVID-19.

Prenatal Steroid Treatment May Improve Survival, Reduce Complications for Extremely Preterm Infants

September 26, 2022 - NCATS News

Antenatal steroid therapy causes the fetal lungs to mature and has been shown to improve survival.

N3C Data Reveal More Severe COVID-19 Outcomes in Rural Communities

September 26, 2022 - NCATS News

  • National Clinical Cohort Collaborative (N3C)

After examining patient health records from the National COVID Cohort Collaborative (N3C), researchers found that people with COVID-19 who live in rural areas are more likely to be hospitalized than those who live in urban areas.

NIH-Funded Study Shows Sound Sleep Supports Immune Function

September 21, 2022 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

Adults who cut back on sleep for six weeks had increased markers of inflammation.

Two Popular Diabetes Drugs Outperformed Others in Large Clinical Trial

September 21, 2022 - NCATS News

  • Compound Management

NIH-funded researchers complete first study comparing commonly used type 2 diabetes medications.

Mount Sinai, NCATS Scientists Uncover a Potential New Path Against Neurological Disease

September 8, 2022 - NCATS News

  • Chemistry Technology

Researchers at the Icahn School of Medicine at Mount Sinai in New York and NCATS identified compounds that, when tested in patient cells and mice, reversed the effects of several neurodegenerative diseases called lysosomal storage disorders (LSDs). The findings could lead to treatments for other neurodegenerative diseases that have similar causes. 

Last updated on July 9, 2026